All these data suggest that P2X7 activation can change the phenotype of glioma cells cultured in vitro more aggressively through enhanced cell proliferation and adhesion to ECM components and ATP release, and by increased expression of chaperones and kinases essential for cancer cell growth. Here, P2RX7 is linked to central nervous system cancer.